Shanxi C&Y Pharmaceutical Group Co Ltd (300254) — Long-term Investment Intensity
Shanxi C&Y Pharmaceutical Group Co Ltd (300254) has a Long-term Investment Intensity of 3.3% as of September 2019. Long-term investments of CN¥51.55 Million represent 3.3% of total assets of CN¥1.56 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check how aggressively does Shanxi C&Y Pharmaceutical Group Co Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Shanxi C&Y Pharmaceutical Group Co Ltd Long-term Investment Intensity (2015–2018)
This chart shows how Shanxi C&Y Pharmaceutical Group Co Ltd's Long-term Investment Intensity has evolved across 4 annual periods from 2015 to 2018. As of September 2019, the intensity stands at 3.3%, reflecting long-term investments of CN¥51.55 Million against total assets of CN¥1.56 Billion CNY. Explore 300254 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Shanxi C&Y Pharmaceutical Group Co Ltd (2015–2018)
The table below presents the year-by-year Long-term Investment Intensity for Shanxi C&Y Pharmaceutical Group Co Ltd from 2015 to 2018, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Shanxi C&Y Pharmaceutical Group Co Ltd (300254) market capitalisation.
| Year | LT Investment Intensity | LT Investments (CNY) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 5.3% | CN¥79.78 Million | CN¥1.50 Billion | ▼ -0.1 pp |
| 2017 | 5.4% | CN¥82.65 Million | CN¥1.52 Billion | ▼ -1.1 pp |
| 2016 | 6.5% | CN¥93.38 Million | CN¥1.43 Billion | ▲ +2.1 pp |
| 2015 | 4.5% | CN¥58.33 Million | CN¥1.31 Billion | — |